Combined Study - Phase 3b MenB Long Term Persistence in Adolescents

NCT02446743 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

531

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL: rMenB+OMV NZ (Meningococcal (Group B) multi component recombinant adsorbed vaccine)

Sponsor

GlaxoSmithKline